Thermo Fisher Scientific Executive and Leadership Team

Marc Casper, the Chairman, President & Chief Executive Officer at Thermo Fisher Scientific, directs the overarching strategic vision for the global life sciences enterprise. Overseeing the integration of laboratory equipment and analytical instrument portfolios, the Chairman, President & Chief Executive Officer ensures alignment between research services and pharmaceutical development goals. This leadership role involves driving long-term value creation through capital allocation and operational excellence across all business segments. By fostering a culture of innovation, Marc Casper directly impacts the ability of the organization to improve lab productivity for customers worldwide. Ultimately, the Chairman, President & Chief Executive Officer secures the market position of the company by scaling diagnostic capabilities and expanding the reach of scientific research tools into emerging healthcare sectors, maintaining a focus on sustainable growth and high-impact technological advancements.

Marc N. Casper, the Chief Executive Officer & Chairman at Thermo Fisher Scientific, architects the high-level governance framework necessary for maintaining global leadership in life sciences. Managing the intersection of analytical instrument manufacturing and research service delivery, the Chief Executive Officer & Chairman drives the strategic roadmap for pharmaceutical development support. This executive function requires constant evaluation of market trends to optimize the deployment of laboratory productivity solutions. By prioritizing the development of medicines through advanced diagnostics, Marc N. Casper directly influences the operational trajectory of the entire organization. Through rigorous oversight of corporate initiatives, the Chief Executive Officer & Chairman ensures that the company remains at the forefront of scientific discovery, consistently delivering value to stakeholders while expanding the footprint of essential research infrastructure across diverse international territories and complex regulatory environments.

Stephen Williamson, the Senior VP & Chief Financial Officer at Thermo Fisher Scientific, directs the financial strategy and fiscal health of the global life sciences organization. Overseeing capital structure, investor relations, and financial planning, the Senior VP & Chief Financial Officer ensures that resources support the development of analytical instruments and research services. This leadership role involves managing the financial risks associated with large-scale pharmaceutical development projects and laboratory equipment manufacturing. By optimizing cost structures and driving margin expansion, Stephen Williamson directly impacts the profitability and growth trajectory of the company. Through rigorous financial analysis and reporting, the Senior VP & Chief Financial Officer provides the board with the insights required to make informed decisions regarding acquisitions and market expansion, ultimately securing the long-term financial stability of the enterprise within the competitive global life sciences landscape.

Vikas Rathi, the Regional Chief Financial Officer (South, East, Asia, Taiwan) at Thermo Fisher Scientific, directs the financial operations and fiscal compliance across key Asian markets. Overseeing regional budgeting, tax strategy, and local investment initiatives, the Regional Chief Financial Officer (South, East, Asia, Taiwan) ensures that financial resources align with the specific needs of the laboratory equipment and diagnostics divisions in these territories. This leadership role involves managing the complexities of cross-border trade and currency fluctuations to maintain operational efficiency. By providing granular financial oversight for regional research services, Vikas Rathi directly impacts the ability of the company to scale its presence in high-growth pharmaceutical sectors. Through the implementation of standardized financial controls, the Regional Chief Financial Officer (South, East, Asia, Taiwan) supports the broader corporate mission of improving lab productivity while ensuring strict adherence to regional regulatory requirements and internal governance standards.

Jennifer Cannon, the President, Commercial Pharma Services at Thermo Fisher Scientific, directs the commercial strategy and operational delivery of services tailored to the pharmaceutical industry. Overseeing the integration of research services and drug development support, the President, Commercial Pharma Services ensures that the company provides the necessary infrastructure for clients to accelerate medicine development. This leadership role involves managing large-scale commercial relationships and ensuring that laboratory productivity solutions meet the rigorous standards of the pharmaceutical sector. By optimizing service delivery models, Jennifer Cannon directly impacts the efficiency of the drug development pipeline for customers. Through the coordination of cross-functional teams, the President, Commercial Pharma Services drives the expansion of the service portfolio, ensuring that the organization remains the preferred partner for pharmaceutical companies seeking to improve research outcomes and bring life-saving treatments to market with greater speed and precision.

Jean Luo, the President, Bioproduction Biologicals and Chemicals Division at Thermo Fisher Scientific, directs the manufacturing and supply chain operations for critical biological and chemical components. Overseeing the production of essential materials used in pharmaceutical development and research, the President, Bioproduction Biologicals and Chemicals Division ensures that the supply chain remains resilient and capable of meeting global demand. This leadership role involves architecting manufacturing processes that prioritize quality, safety, and scalability. By optimizing the production of chemicals and biologicals, Jean Luo directly impacts the ability of the company to support the broader life sciences ecosystem. Through the strategic management of the division, the President, Bioproduction Biologicals and Chemicals Division ensures that researchers and pharmaceutical manufacturers have consistent access to the high-quality inputs required for their work, thereby driving innovation and productivity across the entire global research and development sector.

Michael Kleppinger, the Group President, Commercial Operations Clinical Research at Thermo Fisher Scientific, directs the commercial strategy and operational execution for clinical research services. Overseeing the deployment of diagnostic tools and analytical instruments within clinical trial environments, the Group President, Commercial Operations Clinical Research ensures that research teams achieve maximum productivity. This leadership role involves managing the complex commercial relationships required to support large-scale clinical studies and pharmaceutical development programs. By optimizing the integration of research services into the clinical workflow, Michael Kleppinger directly impacts the speed and accuracy of medical data analysis. Through the strategic oversight of commercial operations, the Group President, Commercial Operations Clinical Research facilitates the successful execution of clinical research initiatives, ensuring that the company provides the essential support needed to advance healthcare outcomes and deliver innovative medicines to patients across the global market.

Tanu Sarkar, the Chief Information Officer, , , & Zealand (India, South, Asia, Australia) at Thermo Fisher Scientific, directs the digital transformation and information technology infrastructure across the Asia-Pacific and Oceania regions. Overseeing the integration of data analytics into laboratory workflows, the Chief Information Officer, , , & Zealand (India, South, Asia, Australia) ensures that regional research teams possess the necessary digital tools to improve productivity. This leadership role involves architecting secure, scalable cloud environments that support complex analytical instrument data processing. By optimizing IT systems for local pharmaceutical development needs, Tanu Sarkar directly impacts the efficiency of scientific research operations. Through the implementation of robust cybersecurity protocols and data management strategies, the Chief Information Officer, , , & Zealand (India, South, Asia, Australia) facilitates seamless collaboration between regional labs and global headquarters, driving technological advancement throughout the entire operational geography.

Shreyas Deo, the Scientist III and Senior Scientist-Client Facing Chief Revenue Officer Environment at Thermo Fisher Scientific, directs the technical engagement strategies that drive revenue growth within client-facing research environments. Overseeing the application of analytical instruments to solve complex customer challenges, the Scientist III and Senior Scientist-Client Facing Chief Revenue Officer Environment ensures that scientific expertise translates into tangible business outcomes. This leadership role involves bridging the gap between laboratory research requirements and the commercial deployment of diagnostic solutions. By optimizing the technical sales funnel and enhancing customer lab productivity, Shreyas Deo directly impacts the revenue generation of the company. Through the delivery of high-value scientific support, the Scientist III and Senior Scientist-Client Facing Chief Revenue Officer Environment fosters long-term partnerships with pharmaceutical developers, ensuring that the technical capabilities of the organization remain perfectly aligned with the evolving needs of the global scientific community.

Richard Andrews, the Vice President OEM and Chief Marketing Officer Services at Thermo Fisher Scientific, directs the global marketing strategy and original equipment manufacturer partnerships. Overseeing the positioning of analytical instruments and research services, the Vice President OEM and Chief Marketing Officer Services ensures that the brand effectively communicates the value of laboratory productivity solutions to pharmaceutical and healthcare clients. This leadership role involves architecting integrated marketing campaigns that highlight the technical superiority of the product portfolio. By expanding the reach of OEM services into new market segments, Richard Andrews directly impacts the growth of the company. Through the strategic alignment of marketing initiatives with customer research needs, the Vice President OEM and Chief Marketing Officer Services drives demand for diagnostic tools, ultimately strengthening the market position of the organization and facilitating the widespread adoption of advanced scientific technologies across the global research landscape.